Georghia Michael
-
New gene therapy CME activity: Updates on Clinical Trials of Gene Therapy in Hemophilia
The World Federation of Hemophilia (WFH) is pleased to announce the launch of the fifth and final activity in Clinical Advances in Gene Therapy for...
-
New gene therapy CME activity: Why Gene Therapy for Hemophilia?
The World Federation of Hemophilia (WFH) is proud to announce the launch of Activity #4 in Clinical Advances in Gene Therapy for Hemophilia, an online...
-
New gene therapy CME activity: The Science of Gene Therapy for Hemophilia
The World Federation of Hemophilia (WFH) is proud to announce the launch of the next activity in Clinical Advances in Gene Therapy for Hemophilia, an...
-
New gene therapy CME program launched
The World Federation of Hemophilia (WFH) is proud to announce the launch of Clinical Advances in Gene Therapy for Hemophilia, an online continuing medical education...
-
Global VWD Call to Action promoted at Congress
Luisa Durante, Program Development Manger, World Federation of Hemophilia (WFH) gathered people with von Willebrand disease (VWD) at the Resource Centre of the WFH 2018...
-
Five von Willebrand Disease Outreach Programs: Secrets to Success
At the World Federation of Hemophilia (WFH) World Congress in Orlando, U.S.A, Andra James (U.S.A.) chaired a discussion between Amy Griffith (Canada), Peter Noun (Lebanon),...
-
Unmet needs and unfinished business in gene therapy
Three experts on gene therapy in hemophilia presented during the final session on day one of the 10th World Federation of Hemophilia Global Forum held...
-
Inhibitors: solving the problem
Three experts on inhibitors in hemophilia opened the first session of the 10th World Federation of Hemophilia (WFH) Global Forum held in Montreal on November...
